Stocktoria
Protalix BioTherapeutics, Inc. PLX
Protalix BioTherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,096,000 | $2.6M | 1.36% |
| CITADEL ADVISORS LLC | 379,427 | $884,065 | 0.47% |
| MILLENNIUM MANAGEMENT LLC | 171,535 | $399,677 | 0.21% |
| AQR CAPITAL MANAGEMENT LLC | 167,826 | $391,035 | 0.21% |
| BlackRock Finance, Inc. | 333,171 | $389,810 | 0.41% |
| TWO SIGMA INVESTMENTS, LP | 42,515 | $99,060 | 0.05% |
| Point72 Asset Management, L.P. | 25,566 | $59,569 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.